12月15日，美国食品药品监督管理局（FDA）批准口服药Addyi的适应证扩展，用于治疗65岁以下绝经后女性的性欲低下症（HSDD）。 Addyi有着“女性伟哥”之称，是全球首个用于治疗“性欲低下”的药物。它曾被寄予厚望，被认为有望成为西地那非后的又一款重磅药物 ...

The Food and Drug Administration has admonished Sprout Pharmaceuticals for running a radio ad that omitted all possible risks associated with its controversial female libido pill and also for giving ...

Sprout Pharmaceuticals Inc. is relaunching Addyi (flibanserin), the first-ever approved drug for low libido, or hypoactive sexual desire disorder (HSDD), which affects up to six million pre-menopausal ...

The Food and Drug Administration (FDA) is considering possible regulatory action, due to a spike in reported adverse events associated with the drug Addyi (flibanserin), which is indicated for ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. When Kara became disinterested in sex with her husband, she knew their relationship wasn't the problem ...

Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...

A new documentary, 'The Pink Pill: Sex, Drugs and Who Has Control,' explores the fight to bring the women’s sexual health pill, Addyi, to market Addyi; Catalyst Works The new documentary, The Pink ...

Following in the footsteps of its predecessor Viagra, the female libido drug Addyi has snuck into over-the-counter supplements that tout their ability to “naturally” enhance sexual desire. The Food ...

PHIL expands direct-to-patient access to Addyi for as low as $40 per year with commercial insurance coverage or $149 per month cash whether accessed through telehealth or a doctor's office. The goal ...

Addyi, the first and only FDA-approved pill clinically proven to treat frustrating low sexual desire in women, is now approved for use in women who have gone through menopause RALEIGH, N.C., Dec. 15, ...

We have recently learned that at this time, the Food and Drug Administration (FDA) has NOT revised its warnings about the use of alcohol with Addyi nor has it changed the drug’s REMS, according to an ...